Connor Walker, PharmD Candidate

Novel therapies such as monoclonal antibodies and phenotype-guided treatments are available and clinicians are using them to help patients with severe asthma.

Current treatment options for patients living with asthma include long acting beta-agonists and inhaled corticoid steroids (ICS). While these therapeutic options are effective in a majority of patients, approximately 10% will remain poorly controlled.